The Greek legislative framework passed two years ago, permits the cultivation & processing of cannabis plants to produce medical cannabis products which contain tetrahydrocannabinol (THC)> 0.2%, thus providing excellent business opportunities for such investments in Greece.
The last three years, medical cannabis industry has a rapid growth at a global scale, with a high investment interest from multinationals (from Canada, USA, Germany, Russia, Israel, etc.) and Greek companies for the development of high tech facilities in Greece, due to estimations that the European market will rise from $ 0.3 billion in 2020 to $ 2.4 billion in 2024 (source: Prohibition Partners).
There is already a high demand for medical cannabis products in Germany, Poland and the UK while it is forecasted that the necessary legislative frames allowing the use of medical cannabis will be passed in France and other countries, within the next 2 years.
Greece, compared to other European countries, is considered an optimum destination for investments of medical cannabis production, as it offers a favorable legislation, an optimum climatic conditions, well-trained scientific staff, and is a member of the European Union, a fact that facilitates exports at ease.
In addition, according to the Greek State’s Medicines Agency (full member of European Medicines Agency – EMA) no clinical trials are required for medical cannabis Products intended to prevent and treat specific conditions such as nausea / vomiting, neuropathic or cancer pains and Multiple Sclerosis.
Worth also noting that following a Greek Ministerial Decision, medical cannabis products containing THC >0.2% are included in Table C, so these products can also be sold through private pharmacies and benefit more than 20,000 patients, while being available in parallel through the state monopoly (e.g through public hospitals).
Process wise, an appropriate land plot needs to be selected meeting all legislative & operational requirements and right after, an application form for the license to build the facility needs to be submitted to the Greek Ministry of Development & Investments.
VK PREMIUM offers an enhanced palette of consulting services to facilitate medical cannabis investments in Greece including strategy & planning, products portfolio as of current & future market trends, land selection and licensing, grants utilizing Investment Incentive Law, design & construction of the facility in accordance with EU GMP & GACP standards and distribution strategies to secure sales success in foreign markets.
Overall, VK PREMIUM is a trust worthy partner with the expertise and long term success records, to facilitate the deployment of Medical Cannabis investments in Greece
Call us at : +30 2106835560, send email to : info[@]vkmedicalcannabis.com or fill the bellow form: